The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The Cleveland Clinic Experience with Adrenal Cortical Carcinoma
Abstract
Between 1936 and 1987, 82 patients with adrenal cortical carcinoma were seen at our clinic. Of these patients 49 (72 per cent) have been seen during the last 25 years. A total of 40 patients (48.8 per cent) presented with a hormonally functional tumor and 42 (51.2 per cent) had a nonfunctional tumor. Forty patients (48.8 per cent) presented with localized disease, 12 (14.6 per cent) with regional disease and 30 (36.6 per cent) with distant metastases. Complete surgical removal of all gross tumor was achieved in 49 patients. Over-all 3 and 5-year patient survival rates in this series were 37.5 and 25.1 per cent, respectively. Survival was significantly improved (43.9 per cent at 5 years, p equals 0.0001) in patients with localized disease that was completely removed surgically; postoperative adjuvant therapy with op'-DDD was of no benefit in these patients. Survival in patients with metastatic disease was poor and was not improved by treatment with op'-DDD, cytotoxic chemotherapy or radiation therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three other studies found radiotherapy to be ineffective on the basis of experiences in 2, 3, and 5 patients, respectively (275, 340, 341).”
From Adrenocortical carcinoma (2014) · cites this paper as [340]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Third national cancer survey: incidence data.
Cutler, S. J., Young, J. L., & Connelly, R. R. (1975) · PubMed · Cited by 537
Hutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90219-1 · Cited by 277
Macfarlane, D. A. (1958) · PubMed · Cited by 266
Estimating survival functions from the life table
Gehan, E. A. (1969) · Journal of Chronic Diseases · doi:10.1016/0021-9681(69)90035-6 · Cited by 260
BERTAGNA, C., & Orth, D. N. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90384-3 · Cited by 245
Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients
Didolkar, M. S., Bescher, R. A., Elias, E. G., & Moore, R. H. (1981) · Cancer · doi:10.1002/1097-0142(19810501)47:9 · Cited by 243
Clinical and pathophysiologic aspects of adrenocortical carcinoma
Lipsett, M. B., Hertz, R., & Ross, G. T. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90179-7 · Cited by 237
FEMINIZING ADRENOCORTICAL TUMORS IN THE MALE
Gabrilove, J. L., Sharma, D. C., Wotiz, H. H., & Dorfman, R. I. (1965) · Medicine · doi:10.1097/00005792-196501000-00002 · Cited by 177
Research works printed but not linked: 1
- Brown, 1979, Adjuvant therapy, o,p′-DDD in the treatment of metastatic adrenocortical carcinoma, Clin. Res., 27, 626A
Cited by
Sorted by citations
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Orth, D. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321207 · Cited by 563
Adrenocortical carcinoma: diagnosis, evaluation and treatment
NG, L., & LIBERTINO, J. M. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)64023-2 · Cited by 423
Metadata
- Authors
- Bodie, B., Novick, A. C., Pontes, J. E., Straffon, R. A., Montie, J. E., Babiak, T., Sheeler, L., & Schumacher, P.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Journal of Urology
- Published
- 1989-02
- Volume
- 141
- Issue
- 2
- Pages
- 257-260
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2415859171
- Cited by
- 145
- References
- 20
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 6
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Urology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, functional adrenal tumors, metastatic disease, surgical resection, adjuvant therapy, cytotoxic chemotherapy, radiotherapy, survival rate
- MeSH terms
- Actuarial Analysis, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Carcinoma, Child, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Mitotane, Ohio, Prognosis, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review